Evidence map›Paper›PMID 28876505›Full record

ArticleCellular microbiology2018

N-(3-Oxo-acyl)-homoserine lactone induces apoptosis primarily through a mitochondrial pathway in fibroblasts.

Aaron M Neely, Guoping Zhao, Christian Schwarzer, Nicole S Stivers, Aaron G Whitt, Shuhan Meng, Joseph A Burlison, Terry E Machen, Chi Li

Open access · bronzeAbstract read
In one paragraph

Article in Cellular microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. mSphere · 2026
    Article
  2. bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Heliyon · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Frontiers in microbiology · 2020
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Aaron M NeelyMolecular Targets Program, James Graham Brown Cancer Center, Departments of Medicine, Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA.
Guoping ZhaoMolecular Targets Program, James Graham Brown Cancer Center, Departments of Medicine, Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA.
Christian SchwarzerDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Nicole S StiversMolecular Targets Program, James Graham Brown Cancer Center, Departments of Medicine, Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA.
Aaron G WhittMolecular Targets Program, James Graham Brown Cancer Center, Departments of Medicine, Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA.
Shuhan MengMolecular Targets Program, James Graham Brown Cancer Center, Departments of Medicine, Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA.
Joseph A BurlisonStructural Biology Program, James Graham Brown Cancer Center, Department of Medicine, University of Louisville, Louisville, KY, USA.
Terry E MachenDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Chi LiMolecular Targets Program, James Graham Brown Cancer Center, Departments of Medicine, Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA.ORCID 0000-0001-8588-2898
University of Louisville · USUniversity of California, Berkeley · US

Funding

NDC for the Optical Control of Biological FunctionPN2EY018241 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI ISACOFF, EHUD · 2006 to 2015
$37.5M
PROJ 12: STEM CELL-BASED VACCINE FOR CANCER PROPHYLAXISP20RR018733 · NCRR · UNIVERSITY OF LOUISVILLE · PI MILLER, DONALD M. · 2003 to 2011
$18.9M
PILOT PROJECT PROGRAMP30GM106396 · NIGMS · UNIVERSITY OF LOUISVILLE · PI MILLER, DONALD M. · 2013 to 2017
$5.4M
University of Louisville Cancer Education ProgramR25CA134283 · NCI · UNIVERSITY OF LOUISVILLE · PI HEIN, DAVID W, KIDD, LA CREIS RENEE · 2011 to 2022
$3.1M
Activating Bax as a therapeutic strategy for lung cancerR01CA175003 · NCI · UNIVERSITY OF LOUISVILLE · PI LI, CHI · 2013 to 2017
$1.5M
Regulation of apoptosis by Bcl-XL, Bak and BaxK01CA106599 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LI, CHI · 2005 to 2009
$787k
NCI NIH HHS K01 CA106599NCI NIH HHS R01 CA175003NCI NIH HHS R25 CA134283NCRR NIH HHS P20 RR018733NEI NIH HHS PN2 EY018241NIGMS NIH HHS P30 GM106396
6 · The paper itself

Abstract

N-(3-Oxododecanoyl)-l-homoserine lactone (C12) is produced by Pseudomonas aeruginosa to function as a quorum-sensing molecule for bacteria-bacteria communication. C12 is also known to influence many aspects of human host cell physiology, including induction of cell death. However, the signalling pathway(s) leading to C12-triggered cell death is (are) still not completely known. To clarify cell death signalling induced by C12, we examined mouse embryonic fibroblasts deficient in "initiator" caspases or "effector" caspases. Our data indicate that C12 selectively induces the mitochondria-dependent intrinsic apoptotic pathway by quickly triggering mitochondrial outer membrane permeabilisation. Importantly, the activities of C12 to permeabilise mitochondria are independent of activation of both "initiator" and "effector" caspases. Furthermore, C12 directly induces mitochondrial outer membrane permeabilisation in vitro. Overall, our study suggests a mitochondrial apoptotic signalling pathway triggered by C12, in which C12 or its metabolite(s) acts on mitochondria to permeabilise mitochondria, leading to activation of apoptosis.

Indexed as

4-ButyrolactoneAnimalsApoptosisCaspase 3Caspase 7Caspase 9Cell Line, TumorCytochromes cFibroblastsHCT116 CellsHomoserineHumansMiceMice, KnockoutMicrobial InteractionsMitochondria4-ButyrolactoneCaspase 3Caspase 7Caspase 9Cytochromes cHomoserinehomoserine lactoneN-(3-oxododecanoyl)homoserine lactoneapoptosiscaspasehomoserine lactonemitochondria

Identifiers

PMID28876505
PMCPMC5729120
OpenAlexW2752578062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.